News & Updates

Pimavanserin well tolerated in older patients with neurodegenerative disease

19 Aug 2023 by

Pimavanserin therapy was well tolerated in frail adult and older patients with neuropsychiatric symptoms related to neurodegenerative disease (NDD) in a recent study presented at AAIC 2023.

Pimavanserin well tolerated in older patients with neurodegenerative disease

19 Aug 2023

Switching antiretroviral regimens does not help with weight loss

18 Aug 2023 by

Switching from an integrase inhibitor (INI)-based antiretroviral treatment (ART) regimen to a protease inhibitor (PI)-based regimen falls short of reversing weight gain while on the INI-based regimen, according to the results of the open-label phase IV DEFINE trial.

Switching antiretroviral regimens does not help with weight loss

18 Aug 2023

Fezolinetant reduces menopause-related vasomotor symptoms

18 Aug 2023 by

Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.

Fezolinetant reduces menopause-related vasomotor symptoms

18 Aug 2023

Radioactive iodine therapy helps prevent papillary thyroid cancer recurrence

18 Aug 2023

Patients with unstimulated thyroglobulin (Tg) ≤1 ng/mL or stimulated Tg ≤10 ng/mL who receive radioactive iodine therapy (RAIT) may benefit from a lower recurrence risk of intermediate-risk papillary thyroid cancer (PTC), reveals a study.

Radioactive iodine therapy helps prevent papillary thyroid cancer recurrence

18 Aug 2023

Oral contraceptive use not linked to CVD, all-cause death in women

18 Aug 2023

Women who use oral contraceptives do not have an excess risk of cardiovascular disease (CVD) events and all-cause death, with the contraceptives potentially conferring benefits to those who have used them for longer, according to a study.

Oral contraceptive use not linked to CVD, all-cause death in women

18 Aug 2023

Long-term hydrochlorothiazide use ups risk of skin cancer

17 Aug 2023

Using hydrochlorothiazide (HCTZ) for longer durations and in higher cumulative doses increases the risks for keratinocyte carcinoma and melanoma, reveals a study.

Long-term hydrochlorothiazide use ups risk of skin cancer

17 Aug 2023

PPI exposure can make children susceptible to serious infections

17 Aug 2023

The use of proton pump inhibitors (PPIs) appears to pose heightened risks of serious infections in young children, according to a study.

PPI exposure can make children susceptible to serious infections

17 Aug 2023

Relugolix combo reduces dysmenorrhea, NMPP in premenopausal women

17 Aug 2023 by

The use of relugolix 40 mg in combination with oestradiol 1 mg and norethisterone acetate 0.5 mg (relugolix combination therapy [relugolix-CT]) significantly reduced dysmenorrhea and nonmenstrual pelvic pain (NMPP) in premenopausal women with endometriosis who received prior hormonal treatment, according to a post hoc analysis of two phase III trials presented at ESHRE 2023.

Relugolix combo reduces dysmenorrhea, NMPP in premenopausal women

17 Aug 2023

Colistin use ups mortality risk in solid organ transplant recipients

16 Aug 2023

Mortality increases threefold when using colistin to treat infections in liver transplant recipients and by 5 percentage points in renal transplant recipients, a study has shown.

Colistin use ups mortality risk in solid organ transplant recipients

16 Aug 2023

Demedicalized delivery of PrEP possible, improves access

16 Aug 2023 by

A peer-led demedicalized delivery of same-day HIV pre-exposure prophylaxis (PrEP) in various community centres is feasible, suggests a Philippines study presented at the recent IAS 2023.

Demedicalized delivery of PrEP possible, improves access

16 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

Pimavanserin well tolerated in older patients with neurodegenerative disease

Pimavanserin well tolerated in older patients with neurodegenerative disease

Switching antiretroviral regimens does not help with weight loss

Switching antiretroviral regimens does not help with weight loss

Fezolinetant reduces menopause-related vasomotor symptoms

Fezolinetant reduces menopause-related vasomotor symptoms

Radioactive iodine therapy helps prevent papillary thyroid cancer recurrence

Radioactive iodine therapy helps prevent papillary thyroid cancer recurrence

Oral contraceptive use not linked to CVD, all-cause death in women

Oral contraceptive use not linked to CVD, all-cause death in women

Long-term hydrochlorothiazide use ups risk of skin cancer

Long-term hydrochlorothiazide use ups risk of skin cancer

PPI exposure can make children susceptible to serious infections

PPI exposure can make children susceptible to serious infections

Relugolix combo reduces dysmenorrhea, NMPP in premenopausal women

Relugolix combo reduces dysmenorrhea, NMPP in premenopausal women

Colistin use ups mortality risk in solid organ transplant recipients

Colistin use ups mortality risk in solid organ transplant recipients

Demedicalized delivery of PrEP possible, improves access

Demedicalized delivery of PrEP possible, improves access